EUVIMEDEUVIMED entdecken
Crossref

SYTL4 acts as a tumor suppressor in colorectal cancer by promoting ubiquitination and degradation of SEC31B

Jinlei Li, Xiaodong Zhang, Hongyan Li, Yating Zheng, Yanyu Chen, Hanbin Wang, Abdourahaman Ibrahim Mohamed Bakour, Xiucai Lan, Yifei Pan, Chunming Ding, Zhenhua Zhou

Biochemical and Biophysical Research Communications · 2026-09 · 831 · 154334

DOI: 10.1016/j.bbrc.2026.154334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Jinlei Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China; Department of Colorectal Anal Surgery,…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Ubiquitination, Vesicular Transport Proteins, Tumor Suppressor Proteins. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Wenzhou Municipal Science and Technology Bureau, National Natural Science Foundation of China, Wenzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) pathogenesis involves complex alterations in tumor suppressor genes and oncogenes. Although ubiquitin-mediated proteolysis represents a well-established regulatory mechanism, the functions of many E3 ubiquitin ligases in CRC remain poorly characterized. In this study, we identified the Rab effector SYTL4 (Synaptotagmin Like 4) as a potential uncharacterized E3 ubiquitin ligase with tumor-suppressive properties in colorectal cancer. Integrated analysis of TCGA and CPTAC datasets, validated with our clinical samples, demonstrated that lower SYTL4 protein abundance correlates strongly with unfavorable clinical outcomes of CRC patients. Functional analyses revealed that SYTL4 overexpression potently suppresses CRC cell proliferation, clonogenicity, and xenograft tumor growth. We identified SEC31B, a structural subunit of COPII vesicle coats, as the primary downstream mediator governed by SYTL4. We further showed that SYTL4 directly interacts with SEC31B and functions as an E3 ubiquitin ligase to trigger K48-type polyubiquitination of SEC31B and subsequent proteasome-dependent degradation. SEC31B exhibited intrinsic oncogenic properties, and its overexpression counteracted the tumor-suppressive effects of SYTL4. Collectively, our results delineate the SYTL4-SEC31B axis as a pivotal regulatory pathway in CRC tumorigenesis, which provides a promising candidate therapeutic target for colorectal cancer clinical intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsUbiquitinationVesicular Transport ProteinsTumor Suppressor ProteinsHumansProteolysisAnimalsCell Line, TumorUbiquitin-Protein LigasesCell ProliferationMice, NudeGenes, Tumor SuppressorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Colorectal cancerSEC31BSYTL4Tumor suppressorUbiquitination

Substanzen

Vesicular Transport ProteinsUbiquitin-Protein LigasesTumor Suppressor Proteins

Autor:innen und Institutionen

  • School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China; Department of Colorectal Anal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou,…
  • Department of Colorectal Anal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
  • School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
  • Hangzhou Medical College, Hangzhou, Zhejiang, 310000, China.
  • Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, No.160 Pujian Road, Shanghai, 200127, China.
  • Department of Colorectal Anal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China. Electronic address: panyifei@wmu.edu.cn.

Förderung

  • Wenzhou Municipal Science and Technology Bureau
  • National Natural Science Foundation of China
  • Wenzhou Medical University

Zitieren

APA

Li, J., Zhang, X., Li, H., Zheng, Y., Chen, Y., Wang, H., Bakour, A. I. M., Lan, X., Pan, Y., Ding, C., & Zhou, Z. (2026). SYTL4 acts as a tumor suppressor in colorectal cancer by promoting ubiquitination and degradation of SEC31B. Biochemical and Biophysical Research Communications, 831, 154334. https://doi.org/10.1016/j.bbrc.2026.154334

Vancouver

Li J, Zhang X, Li H, Zheng Y, Chen Y, Wang H, et al. SYTL4 acts as a tumor suppressor in colorectal cancer by promoting ubiquitination and degradation of SEC31B. Biochemical and Biophysical Research Communications. 2026;831:154334. doi:10.1016/j.bbrc.2026.154334

BibTeX
@article{Li2026,
  author = {Li, Jinlei and Zhang, Xiaodong and Li, Hongyan and Zheng, Yating and Chen, Yanyu and Wang, Hanbin and Bakour, Abdourahaman Ibrahim Mohamed and Lan, Xiucai and Pan, Yifei and Ding, Chunming and Zhou, Zhenhua},
  title = {SYTL4 acts as a tumor suppressor in colorectal cancer by promoting ubiquitination and degradation of SEC31B},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {831},
  pages = {154334},
  doi = {10.1016/j.bbrc.2026.154334}
}
Kostenlos starten →